FDA Approves Ebola Vaccine

FDA Approves Ebola Vaccine

The very first Ebola vaccine has been approved by the United States Food and Drug Administration. It has already been sent to the Congo to fight the Ebola outbreak in the region.
Ervebo, the said vaccine, was developed by Merck. It was tested from 2014 to 2016 during the outbreak of Ebola in West Africa. It fought the illness with flying colors. The USFDA approved the vaccine for individuals at least eighteen years of age. Even if Ebola virus infection is rare in the USA, the vaccine would help prevent the disease from spreading if it does infect people in the country.
At least 250,000 people in Africa have been vaccinated. Since then, the outbreak is being controlled. Experimental treatments have also started for infected individuals. Out of four treatments, two have been proven to prevent death from Ebola infection.
Currently, there has been a decline in new Ebola cases, but Africa’s conditions are still dangerous for people who are fighting the disease. Just late November this year, armed people killed four health workers who assist in the vaccinations.